Buy BPC-157 UK: Research Peptide Vials, Prices and Published COA

For in-vitro laboratory research use only. Not for human or veterinary use. Corex Vitality™ supplies research compounds to adults (18+) for laboratory research. Nothing on this page is medical advice.

Corex Vitality™ supplies BPC-157 as a lyophilised (freeze-dried) research peptide for in-vitro laboratory work in the UK. This page covers what the compound is, what the published research looks like, what to check before you buy from any supplier, and the sizes, prices and Certificate of Analysis (COA) we currently publish.

At a glance

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide. Its sequence comes from a larger protein first described in gastric juice, which is where the name “body protection compound” comes from. The research-grade material is made by solid-phase peptide synthesis, purified by HPLC and freeze-dried into a powder.

For a laboratory, the useful facts are its sequence, molecular weight, purity and the quality of the batch documentation. Those are what this page focuses on.

What has been studied? (preclinical research only)

Almost all published work on BPC-157 is preclinical. That means cell-culture (in-vitro) studies and animal models. There are no completed large-scale published research studies, and no regulator has approved BPC-157 as a medicine.

Examples of the kinds of questions researchers have asked:

• Cell signalling in culture. One in-vitro study used fibroblasts isolated from rat tendon tissue. It reported higher growth hormone receptor expression at the mRNA and protein level after BPC-157 exposure, measured by microarray, RT-PCR and Western blot [1].
• Analytical detection and metabolism. Anti-doping laboratories have developed LC-MS methods to detect BPC-157 and its breakdown products, and have studied how the peptide is broken down in plasma and other in-vitro systems [2][3]. This work is useful background for anyone designing analytical methods for the compound.
• Peptide impurities. Like every synthetic peptide, BPC-157 can carry synthesis-related impurities such as deletion sequences, oxidation products and counter-ions. A review of peptide-related impurities explains how these arise and how chromatography is used to find them [4].

Findings from cell or animal models cannot be applied to people. Corex Vitality™ does not make any claim about what BPC-157 does in the body.

What to check before you buy BPC-157 in the UK

Use the same checks with any supplier, including us.

1. A COA you can open without logging in. It should show the laboratory name, a report or batch number, the test date and the HPLC purity result.
2. A size-matched COA. Check which vial size the COA was run on. Our BPC-157 COAs are for a 5mg batch (LDA22162336) and a 10mg batch (LDA22161152).
3. A way to confirm the report. Lingda Laboratory COAs carry a QR code. Scan it to check the report on the laboratory’s own site. Our guide to verifying a peptide COA walks through each step.
4. Claims that match the certificate. If a supplier says “identity confirmed by mass spectrometry”, the COA should show it. Our BPC-157 COA reports HPLC purity and does not include a mass-spectrometry identity test.
5. Purity is not the same as peptide content. HPLC purity tells you how much of the detected material is the target peptide. It does not tell you the net peptide content of the vial. See HPLC purity vs net peptide content.
6. A real UK business. Look for a company number, a registered address and a data-protection (ICO) registration.
7. Research-only presentation. A supplier that gives human-use instructions or health claims is not selling a research compound. Under the Human Medicines Regulations 2012, that presentation can make a product a medicine.

What our BPC-157 COA shows

The 10mg BPC-157 COA is report LDA22161152 from Lingda Laboratory. The test date is 3 September 2026, and the sample is a 10mg finished vial. The laboratory was commissioned by the manufacturer or supplier. The COA is published exactly as issued.

Open the BPC-157 COA on our verification page

Coverage: the COA was run on the 10mg size. There is no separate COA for the 5mg, 2mg or 20mg sizes.

Corex Vitality™ BPC-157: sizes and prices

View BPC-157 research peptide

• Multi-Vial Savings: 10% off 2 vials and 15% off 3 or more. You can mix and match sizes and compounds. The saving is applied automatically in the basket.
• Delivery: free next-day tracked delivery on in-stock orders over £50. See Shipping Information.
• Laboratory solvent: BAC Water comes in 3ml (£3.99) and 10ml (£5.99). The 10ml size is free on lyophilised vial orders over £100.

Related research compounds

Storage of lyophilised BPC-157

Store sealed vials cool, dry and away from light, as described in our lyophilised peptide storage guide. Peptides in solution are generally less stable than the dried powder, so laboratories usually prepare solutions only when they need them.

FAQ

Research the range

• Research peptides UK: range, prices and COAs
• How to verify a peptide COA
• Search all published COAs
• Counter-ions: TFA vs acetate

References

All references were checked against PubMed using NCBI E-utilities on 2 Nov 2026. They are listed for scientific background only. They are not claims about any Corex Vitality™ product.

1. Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014;19(11):19066-77. doi:10.3390/molecules191119066. PMID 25415472
2. Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H. Drug Test Anal. 2017;9(10):1490-1498. doi:10.1002/dta.2152. PMID 28035768
3. Tian T, Jing J, Li Y, et al. Stable isotope labeling-based nontargeted strategy for characterization of the in vitro metabolic profile of a novel doping BPC-157 in doping control by UHPLC-HRMS. Molecules. 2023;28(21):7345. doi:10.3390/molecules28217345. PMID 37959764
4. D’Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. doi:10.1016/j.jpba.2014.06.012. PMID 25044089